Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/11063
Type
ArticleCopyright
Restricted access
Collections
- IOC - Artigos de Periódicos [12734]
Metadata
Show full item record
DIFFERENTIAL TLR2 DOWNSTREAM SIGNALING REGULATES LIPID METABOLISM AND CYTOKINE PRODUCTION TRIGGERED BY MYCOBACTERIUM BOVIS BCG INFECTION
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil / Universidade Federal de Juiz de Fora. Laboratório de Biologia Celular. Juiz de Fora, MG, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil .
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil / Universidade de Brasília. Laboratório de Imunologia e Inflamação. Brasília, DF, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Microbiologia Celular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
National Center for Scientific Research (CNRS). Orleans, France / University of Orleans. Experimental and Molecular Immunology and Neurogenetics. France.
National Center for Scientific Research (CNRS). Orleans, France / University of Orleans. Experimental and Molecular Immunology and Neurogenetics. France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil .
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil .
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil / Universidade de Brasília. Laboratório de Imunologia e Inflamação. Brasília, DF, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Microbiologia Celular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
National Center for Scientific Research (CNRS). Orleans, France / University of Orleans. Experimental and Molecular Immunology and Neurogenetics. France.
National Center for Scientific Research (CNRS). Orleans, France / University of Orleans. Experimental and Molecular Immunology and Neurogenetics. France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil .
Abstract
The nuclear receptor PPARγ acts as a key modulator of lipid metabolism, inflammation and pathogenesis in BCGinfected
macrophages. However, the molecular mechanisms involved in PPARγ expression and functions during
infection are not completely understood. Here, we investigate signaling pathways triggered by TLR2, the involvement
of co-receptors and lipid rafts in the mechanism of PPARγ expression, lipid body formation and cytokine
synthesis in macrophages during BCG infection. BCG induces NF-κB activation and increased PPARγ expression
in a TLR2-dependent manner. Furthermore, BCG-triggered increase of lipid body biogenesis was inhibited by
the PPARγ antagonist GW9662, but not by the NF-κB inhibitor JSH-23. In contrast, KC/CXCL1 production was
largely dependent on NF-κB but not on PPARγ. BCG infection induced increased expression of CD36 in
macrophages in vitro. Moreover, CD36 co-immunoprecipitates with TLR2 in BCG-infected macrophages, suggesting
its interaction with TLR2 in BCG signaling. Pretreatment with CD36 neutralizing antibodies significantly
inhibited PPARγ expression, lipid body formation and PGE2 production induced by BCG. Involvement of CD36 in
lipid body formation was further confirmed by decreased BCG-induced lipid body formation in CD36 deficient
macrophages. Similarly, CD14 and CD11b/CD18 blockage also inhibited BCG-induced lipid body formation,
whereas TNF-α synthesis was not affected. Disruption of rafts recapitulates the latter result, inhibiting lipid
body formation, but not TNF-α synthesis in BCG-infected macrophages. In conclusion, our results suggest that
CD36-TLR2 cooperation and signaling compartmentalization within rafts, divert host response signaling through
PPARγ-dependent and NF-κB-independent pathways, leading to increased macrophage lipid accumulation and
down-modulation of macrophage response.
Share